Compounds > nifekalant hydrochloride
Page last updated: 2024-09-03

nifekalant hydrochloride and n-methylscopolamine

nifekalant hydrochloride has been researched along with n-methylscopolamine in 1 studies

Compound Research Comparison

Studies
(nifekalant hydrochloride)		Trials
(nifekalant hydrochloride)		Recent Studies (post-2010)
(nifekalant hydrochloride)		Studies
(n-methylscopolamine)		Trials
(n-methylscopolamine)		Recent Studies (post-2010) (n-methylscopolamine)
13816381,0261252

Protein Interaction Comparison

ProteinTaxonomynifekalant hydrochloride (IC50)n-methylscopolamine (IC50)
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.335
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.0023
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.0023
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.0018
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.0011

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endou, M; Hara, Y; Mori, K; Nakaya, H; Uemura, H1

Other Studies

1 other study(ies) available for nifekalant hydrochloride and n-methylscopolamine

ArticleYear
Interaction of class III antiarrhythmic drugs with muscarinic M2 and M3 receptors: radioligand binding and functional studies.
    Naunyn-Schmiedeberg's archives of pharmacology, 1995, Volume: 353, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Myocardial Contraction; N-Methylscopolamine; Pyrimidinones; Radioligand Assay; Receptors, Muscarinic; Scopolamine Derivatives; Sotalol

1995